Evaluation of Outcomes From Treatment of Benign or Malignant Gastroesophageal Diseases (NCT04637256) | Clinical Trial Compass
CompletedNot Applicable
Evaluation of Outcomes From Treatment of Benign or Malignant Gastroesophageal Diseases
United States500 participantsStarted 2019-03-06
Plain-language summary
This study will be a retrospective chart review of patients who have been diagnosed with benign or malignant pancreatic disease under the practice of Dr. Rohan Jeyarajah, M.D., Dr. Houssam Osman M.D., and Dr. Edward Cho M.D., Sc.M. at Methodist Health System Hospital in Richardson, Texas. The Investigators plan to conduct an analysis of patients meeting the inclusion criteria from 2005 to present. Study will also be conducted by the PI, Sub-Is, surgery fellows, office staff and clinical research coordinator who are delegated to do by the PI. Data will be obtained by looking through either the investigator's patients from their practice or through a national database. Data will be analyzed primarily by the study conductors.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* All patients diagnosed and treated for gastroesophageal diseases, benign or malignant from 2005 to present.
* Age ≥18 years
Exclusion Criteria:
* Patients that are not diagnosed with or treated for gastroesophageal diseases
* Age \< 18 years
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial has already been completed and was measuring overall survival in pancreatic cancer patients — has the data been published yet, and would you be able to walk me through what the results showed about how long patients lived?
2Since this was a study evaluating 'outcomes from treatment' rather than testing a new drug, does that mean it was primarily observational, and if so, how might the findings from this registry-style study actually change the way you would approach my treatment?
3The trial covered a broad range of gastroesophageal diseases including pancreatic cancer — do you know which specific treatments or interventions were being evaluated, and are any of those approaches something you'd consider relevant to my particular situation?
4Given that this trial is now completed and was not assigned a specific phase, meaning it wasn't a traditional drug trial, should I be looking at other active clinical trials that are actually testing new therapies for pancreatic cancer, and would that be a better next step for me?
5Are there findings from this completed study that might help inform whether standard treatment options or a newer approach would be more appropriate for where my cancer currently stands?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.